AAPL   322.32 (-0.86%)
MSFT   182.92 (-1.32%)
FB   226.29 (-1.68%)
GOOGL   1,414.30 (-1.73%)
AMZN   2,460.60 (-0.72%)
NVDA   350.66 (-0.03%)
CGC   16.63 (+0.36%)
BABA   218.04 (-0.26%)
MU   51.22 (+4.70%)
GE   7.74 (+5.16%)
TSLA   864.38 (-2.10%)
AMD   52.63 (-0.19%)
T   31.80 (+0.92%)
ACB   14.23 (-0.49%)
F   6.57 (+6.14%)
GILD   77.54 (+4.22%)
DIS   123.69 (+1.24%)
NFLX   414.33 (-1.81%)
BAC   26.78 (+3.04%)
BA   184.30 (+6.43%)
AAPL   322.32 (-0.86%)
MSFT   182.92 (-1.32%)
FB   226.29 (-1.68%)
GOOGL   1,414.30 (-1.73%)
AMZN   2,460.60 (-0.72%)
NVDA   350.66 (-0.03%)
CGC   16.63 (+0.36%)
BABA   218.04 (-0.26%)
MU   51.22 (+4.70%)
GE   7.74 (+5.16%)
TSLA   864.38 (-2.10%)
AMD   52.63 (-0.19%)
T   31.80 (+0.92%)
ACB   14.23 (-0.49%)
F   6.57 (+6.14%)
GILD   77.54 (+4.22%)
DIS   123.69 (+1.24%)
NFLX   414.33 (-1.81%)
BAC   26.78 (+3.04%)
BA   184.30 (+6.43%)
AAPL   322.32 (-0.86%)
MSFT   182.92 (-1.32%)
FB   226.29 (-1.68%)
GOOGL   1,414.30 (-1.73%)
AMZN   2,460.60 (-0.72%)
NVDA   350.66 (-0.03%)
CGC   16.63 (+0.36%)
BABA   218.04 (-0.26%)
MU   51.22 (+4.70%)
GE   7.74 (+5.16%)
TSLA   864.38 (-2.10%)
AMD   52.63 (-0.19%)
T   31.80 (+0.92%)
ACB   14.23 (-0.49%)
F   6.57 (+6.14%)
GILD   77.54 (+4.22%)
DIS   123.69 (+1.24%)
NFLX   414.33 (-1.81%)
BAC   26.78 (+3.04%)
BA   184.30 (+6.43%)
AAPL   322.32 (-0.86%)
MSFT   182.92 (-1.32%)
FB   226.29 (-1.68%)
GOOGL   1,414.30 (-1.73%)
AMZN   2,460.60 (-0.72%)
NVDA   350.66 (-0.03%)
CGC   16.63 (+0.36%)
BABA   218.04 (-0.26%)
MU   51.22 (+4.70%)
GE   7.74 (+5.16%)
TSLA   864.38 (-2.10%)
AMD   52.63 (-0.19%)
T   31.80 (+0.92%)
ACB   14.23 (-0.49%)
F   6.57 (+6.14%)
GILD   77.54 (+4.22%)
DIS   123.69 (+1.24%)
NFLX   414.33 (-1.81%)
BAC   26.78 (+3.04%)
BA   184.30 (+6.43%)
Log in

NASDAQ:TRNSTranscat Stock Price, Forecast & News

$25.22
+0.13 (+0.52 %)
(As of 06/4/2020 04:00 PM ET)
Add
Compare
Today's Range
$25.22
Now: $25.22
$25.96
50-Day Range
$24.24
MA: $26.68
$28.89
52-Week Range
$16.50
Now: $25.22
$34.18
Volume15,900 shs
Average Volume26,635 shs
Market Capitalization$186.12 million
P/E Ratio23.35
Dividend YieldN/A
Beta0.7
Transcat, Inc. provides calibration and laboratory instrument services in North America and internationally. It operates in two segments, Service and Distribution. The Service segment offers calibration, repair, inspection, analytical qualification, preventative maintenance, consulting, and other related services. This segment also provides CalTrak, a proprietary document and asset management software that is used to integrate and manage the workflow of its calibration service centers and customers' assets; CalTrak Online, which provides its customers with Web-based asset management capability, as well as a safe and secure off-site archive of calibration and other service records; and Compliance, Control and Cost, a cloud-based customer portal and asset management tool. The Distribution segment sells and rents test, measurement, and control instruments for customers' test and measurement instrumentation needs. This segment markets and sells its products through Website, digital and print advertising, proactive outbound sales, and an inbound call center. The company provides services and products to highly regulated industries, principally life science, which includes companies in the pharmaceutical, biotechnology, medical device, and other FDA-regulated industries; and additional industries, including industrial manufacturing, oil and gas and alternative energy, aerospace and defense, and other industries that require accuracy in processes and confirmation of the capabilities of their equipment. Transcat, Inc. was founded in 1964 and is headquartered in Rochester, New York.
Read More
Transcat logo

Beat the Market (BTM) Rank

Analyst Opinion: 3.5Community Rank: 2.7Dividend Strength: 0.0Insider Behavior: 4.0Valuation: 2.5 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

2.54 out of 5 stars


Industry, Sector and Symbol

Industry Instruments to measure electricity
Sub-IndustryN/A
Current SymbolNASDAQ:TRNS
CUSIPN/A
Phone585-352-7777

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$173.10 million
Cash Flow$1.88 per share
Book Value$8.27 per share

Profitability

Net Income$8.07 million

Miscellaneous

Employees571
Market Cap$186.12 million
Next Earnings Date7/28/2020 (Estimated)
OptionableNot Optionable

Receive TRNS News and Ratings via Email

Sign-up to receive the latest news and ratings for TRNS and its competitors with MarketBeat's FREE daily newsletter.

Transcat (NASDAQ:TRNS) Frequently Asked Questions

How has Transcat's stock been impacted by COVID-19 (Coronavirus)?

Transcat's stock was trading at $27.83 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization. Since then, TRNS shares have decreased by 9.4% and is now trading at $25.22. View which stocks have been most impacted by Coronavirus.

Do Wall Street analysts recommend investors buy shares of Transcat?

3 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Transcat in the last year. There are currently 3 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View analyst ratings for Transcat.

When is Transcat's next earnings date?

Transcat is scheduled to release its next quarterly earnings announcement on Tuesday, July 28th 2020. View our earnings forecast for Transcat.

How were Transcat's earnings last quarter?

Transcat, Inc. (NASDAQ:TRNS) posted its earnings results on Tuesday, May, 19th. The scientific and technical instruments company reported $0.33 EPS for the quarter, topping the Zacks' consensus estimate of $0.28 by $0.05. The scientific and technical instruments company had revenue of $45.76 million for the quarter, compared to analysts' expectations of $45.50 million. Transcat had a net margin of 4.66% and a return on equity of 12.86%. View Transcat's earnings history.

What price target have analysts set for TRNS?

3 brokers have issued 12-month price targets for Transcat's stock. Their forecasts range from $34.50 to $42.00. On average, they anticipate Transcat's stock price to reach $37.17 in the next twelve months. This suggests a possible upside of 47.4% from the stock's current price. View analysts' price targets for Transcat.

Has Transcat been receiving favorable news coverage?

Press coverage about TRNS stock has trended somewhat positive recently, InfoTrie Sentiment reports. The research firm scores the sentiment of press coverage by monitoring more than six thousand news and blog sources. The firm ranks coverage of public companies on a scale of negative five to five, with scores nearest to five being the most favorable. Transcat earned a media sentiment score of 1.6 on InfoTrie's scale. They also assigned news stories about the scientific and technical instruments company a news buzz of 0.0 out of 10, indicating that recent press coverage is extremely unlikely to have an effect on the stock's share price in the next several days. View the latest news aboutTranscat.

Who are some of Transcat's key competitors?

What other stocks do shareholders of Transcat own?

Who are Transcat's key executives?

Transcat's management team includes the following people:
  • Mr. Lee D. Rudow, Pres, CEO & Director (Age 55)
  • Mr. Michael J Tschiderer, VP of Fin., CFO, Treasurer & Corp. Sec. (Age 59)
  • Mr. Robert A. Flack, VP of Service Sales & Operations (Age 49)
  • Mr. Scott D. Deverell, Corp. Controller & Principal Accounting Officer (Age 53)
  • Mr. Michael W. West, VP of Inside Sales & Marketing (Age 48)

What is Transcat's stock symbol?

Transcat trades on the NASDAQ under the ticker symbol "TRNS."

Who are Transcat's major shareholders?

Transcat's stock is owned by a variety of institutional and retail investors. Top institutional investors include Wasatch Advisors Inc. (6.14%), BlackRock Inc. (5.69%), Minerva Advisors LLC (4.51%), THB Asset Management (2.65%), Dalton Greiner Hartman Maher & Co. (2.13%) and ArrowMark Colorado Holdings LLC (2.04%). Company insiders that own Transcat stock include Alan H Resnick, Carl E Sassano, Charles P Hadeed, Gary J Haseley, John T Smith, Michael Tschiderer, Richard J Harrison, Robert A Flack and Scott Deverell. View institutional ownership trends for Transcat.

Which institutional investors are selling Transcat stock?

TRNS stock was sold by a variety of institutional investors in the last quarter, including Wellington Management Group LLP, Dalton Greiner Hartman Maher & Co., THB Asset Management, ArrowMark Colorado Holdings LLC, Grandeur Peak Global Advisors LLC, Morgan Stanley, BlackRock Inc., and Minerva Advisors LLC. Company insiders that have sold Transcat company stock in the last year include Carl E Sassano, Charles P Hadeed, John T Smith, Robert A Flack, and Scott Deverell. View insider buying and selling activity for Transcat.

Which institutional investors are buying Transcat stock?

TRNS stock was acquired by a variety of institutional investors in the last quarter, including Wasatch Advisors Inc., State Street Corp, UBS Group AG, Invesco Ltd., Needham Investment Management LLC, Geode Capital Management LLC, Anchor Capital Advisors LLC, and Russell Investments Group Ltd.. Company insiders that have bought Transcat stock in the last two years include Gary J Haseley, and Michael Tschiderer. View insider buying and selling activity for Transcat.

How do I buy shares of Transcat?

Shares of TRNS can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Transcat's stock price today?

One share of TRNS stock can currently be purchased for approximately $25.22.

How big of a company is Transcat?

Transcat has a market capitalization of $186.12 million and generates $173.10 million in revenue each year. The scientific and technical instruments company earns $8.07 million in net income (profit) each year or $1.08 on an earnings per share basis. Transcat employs 571 workers across the globe.

What is Transcat's official website?

The official website for Transcat is www.transcat.com.

How can I contact Transcat?

Transcat's mailing address is 35 VANTAGE POINT DRIVE, ROCHESTER NY, 14624. The scientific and technical instruments company can be reached via phone at 585-352-7777 or via email at [email protected]

This page was last updated on 6/4/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.